Lucira Health, Inc

Lucira Health, Inc, based in Emeryville, CA, introduces LUCIRA® by Pfizer, the pioneer at-home molecular test designed to swiftly differentiate between COVID-19 and the flu in just 30 minutes. This groundbreaking product, LUCIRA® by Pfizer, offers the unique advantage of 2-in-1 molecular testing for both COVID-19 and Flu A/B, all easily conducted at home.

Authorized for emergency use by the FDA, LUCIRA® by Pfizer focuses on the detection and differentiation of nucleic acid from SARS-CoV-2, influenza A, and influenza B. This authorization is granted under specific circumstances justifying the emergency use of diagnostic tools for COVID-19, signifying the innovative nature of this testing solution.

With LUCIRA® by Pfizer, individuals and families can swiftly determine whether their viral respiratory symptoms stem from COVID-19 and/or the flu, facilitating prompt communication with healthcare providers for necessary care or treatment. This product offers the convenience of lab-quality testing within the comfort of one's own home through a straightforward three-step process: Swab, Stir, and Detect.

Generated from the website content